MedTrace Logo

Deprescribing: a Portrait and Out-comes of the Reduction of Polypharmacy in Portugal

NCT03283735 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2018-02-19

No results posted yet for this study

Summary

This study protocol comprises three phases. The first two phases will be nationwide and aim to evaluate the prevalence and patterns of polypharmacy and assess the barriers and facilitators of deprescribing perceived by older adults, as well as their willingness to be deprescribed and to self-medicate. The third and last phase will be a non-pharmacological randomised clinical study to measure the impact of enablement of older adults in their willingness to be deprescribed and related quality of life.

Conditions

  • Polypharmacy
  • Deprescriptions

Interventions

BEHAVIORAL

Elderly Enablement

The information given in this group will result from the knowledge obtained in previous phase of the study in the shape of small leaflets and other information materials to be made according to the best practice, to be given and remembered at scheduled times to the intervention group

Sponsors & Collaborators

  • University of Beira Interior

    lead OTHER

Principal Investigators

  • Pedro Augusto Simões, Master · University of Beira Interior

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-04-01
Completion
2020-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03283735 on ClinicalTrials.gov